|
EHBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.382400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.685800E-01 |
| Normal-vs-Stage2 |
1.226110E-02 |
| Normal-vs-Stage3 |
8.056400E-01 |
| Normal-vs-Stage4 |
2.374000E-01 |
| Stage1-vs-Stage2 |
4.428100E-02 |
| Stage1-vs-Stage3 |
4.530400E-01 |
| Stage1-vs-Stage4 |
1.113150E-01 |
| Stage2-vs-Stage3 |
1.461800E-02 |
| Stage2-vs-Stage4 |
3.318300E-03 |
| Stage3-vs-Stage4 |
3.396200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.282800E-01 |
| Normal-vs-AfricanAmerican |
2.917400E-01 |
| Normal-vs-Asian |
2.917600E-01 |
| Caucasian-vs-AfricanAmerican |
3.633800E-01 |
| Caucasian-vs-Asian |
1.985230E-01 |
| AfricanAmerican-vs-Asian |
1.347980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.081000E-01 |
| Normal-vs-Female |
9.608400E-01 |
| Male-vs-Female |
1.736240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.240200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.616200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.999200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.863200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.134960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.959200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.937400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.485400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.804000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.904800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.495640E-03 |
| Classical-VS-Follicular |
1.66533453693773E-15 |
| Classical-VS-Other |
1.562810E-01 |
| Classical-VS-Normal |
2.347000E-01 |
| Tall-VS-Follicular |
2.19824158875781E-14 |
| Tall-VS-Other |
4.418200E-03 |
| Tall-VS-Normal |
4.757600E-04 |
| Follicular-VS-Other |
2.421800E-01 |
| Follicular-VS-Normal |
2.43009999900679E-08 |
| Other-VS-Normal |
1.152970E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.453860E-02 |
| Normal-vs-N1 |
8.728800E-01 |
| N0-vs-N1 |
1.274770E-01 |
|
|
